Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $349.64 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $119.44 | 9 | $0 (2024) |
| ABBVIE INC. | $77.59 | 3 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $71.21 | 7 | $0 (2019) |
| Abbott Laboratories | $39.30 | 2 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $14.70 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $13.97 | 1 | $0 (2018) |
| Dexcom, Inc. | $13.43 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.23 | 3 | ABBVIE INC. ($27.48) |
| 2023 | $52.26 | 3 | AbbVie Inc. ($22.50) |
| 2022 | $61.78 | 3 | ABBVIE INC. ($27.61) |
| 2019 | $56.23 | 5 | Sunovion Pharmaceuticals Inc. ($37.12) |
| 2018 | $61.36 | 5 | Amgen Inc. ($47.39) |
| 2017 | $57.78 | 5 | Sunovion Pharmaceuticals Inc. ($34.09) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Inflammation | ||||||
| 03/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes Care | ||||||
| 09/21/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Inflammation | ||||||
| 03/10/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 10/21/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Diabetes Care | ||||||
| 10/19/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Endocrinology | ||||||
| 06/15/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/26/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Neuroscience | ||||||
| 02/07/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $7.69 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: RESPIRATORY | ||||||
| 10/16/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: Neuroscience | ||||||
| 08/14/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Neuroscience | ||||||
| 05/01/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Cardiology | ||||||
| 01/24/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: UROLOGY | ||||||
| 01/16/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Cardiology | ||||||
| 10/31/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2017 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $10.40 | General |
| 07/19/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Endocrinology | ||||||
| 02/08/2017 | Sunovion Pharmaceuticals Inc. | BROVANA (Drug) | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,595 | 3,538 | $494,444 | $174,320 |
| 2022 | 19 | 1,534 | 3,333 | $357,980 | $137,744 |
| 2021 | 20 | 1,285 | 3,167 | $363,145 | $136,142 |
| 2020 | 17 | 1,222 | 1,765 | $281,800 | $92,604 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 420 | 746 | $198,421 | $57,842 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 443 | $79,080 | $25,822 | 32.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,320 | $36,036 | $24,254 | 67.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 221 | 223 | $21,526 | $16,802 | 78.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $43,434 | $10,878 | 25.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 35 | 35 | $10,453 | $9,848 | 94.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 61 | 61 | $41,797 | $9,190 | 22.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 35 | 38 | $19,217 | $5,464 | 28.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 205 | 207 | $4,103 | $4,001 | 97.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 14 | 15 | $10,827 | $3,055 | 28.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $6,437 | $1,999 | 31.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 31 | 49 | $7,830 | $1,853 | 23.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 77 | 136 | $7,480 | $1,295 | 17.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,628 | $823.02 | 50.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 86 | $4,229 | $756.00 | 17.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 22 | 24 | $1,673 | $409.34 | 24.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 13 | $271.70 | $28.60 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 344 | 570 | $140,745 | $45,425 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 284 | 445 | $72,837 | $24,686 | 33.9% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,320 | $36,036 | $22,586 | 62.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 244 | 244 | $22,104 | $17,126 | 77.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $29,279 | $8,485 | 29.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 249 | 250 | $4,955 | $4,858 | 98.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 19 | 21 | $9,993 | $3,050 | 30.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 15 | 15 | $9,542 | $2,347 | 24.6% |
About Dr. Patrick Brown, MD
Dr. Patrick Brown, MD is a Family Medicine healthcare provider based in Scottsbluff, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023025533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Brown, MD has received a total of $349.64 in payments from pharmaceutical and medical device companies, with $60.23 received in 2024. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($349.64).
As a Medicare-enrolled provider, Brown has provided services to 5,636 Medicare beneficiaries, totaling 11,803 services with total Medicare billing of $540,811. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Scottsbluff, NE
- Active Since 08/01/2006
- Last Updated 04/02/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1023025533
Products in Payments
- LINZESS (Drug) $50.11
- Aimovig (Biological) $44.77
- LONHALA MAGNAIR (Drug) $37.12
- Otezla (Drug) $29.25
- CREON (Drug) $27.48
- UTIBRON (Drug) $25.44
- Repatha (Biological) $21.73
- FREESTYLE LIBRE 2 (Device) $20.74
- FREESTYLE LIBRE 3 (Device) $18.56
- GVOKE HYPOPEN (Drug) $14.70
- MYRBETRIQ (Drug) $13.97
- Dexcom G6 Transmitter (Medical Supply) $13.43
- Prolia (Biological) $13.29
- BROVANA (Drug) $8.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Scottsbluff
Dr. Michelle Cheloha, M.d, M.D
Family Medicine — Payments: $2,328
Dr. Kent Lacey, M.d, M.D
Family Medicine — Payments: $2,112
Dr. Lodewyk Papenfus, M.d, M.D
Family Medicine — Payments: $1,983
John Blomstedt, Do, DO
Family Medicine — Payments: $1,784
Dr. Lindsey Mosel, M.d, M.D
Family Medicine — Payments: $1,695
Kathryn Painter, Md, MD
Family Medicine — Payments: $726.88